Symbols

PPH

VanEck Pharmaceutical ETF·NASDAQ

--(--)

Key Stats

Assets Under Management

1.19BUSD

Fund Flows (1Y)

407.37MUSD

Dividend Yield

1.66%

Discount/Premium to NAV

-0.04%

Shares Outstanding

10.79M

Expense Ratio

0.36%

About VanEck Pharmaceutical ETF

Issuer

Van Eck Associates Corporation

Brand

VanEck

Home Page

https://www.vaneck.com/us/en/investments/pharmaceutical-etf-pph/

Inception Date

Dec 20, 2011

Structure

Open-Ended Fund

Index Tracked

MVIS US Listed Pharmaceutical 25 Index

Management Style

Passive

Dividend Treatment

Distributes

Distribution Tax Treatment

Qualified dividends

Income Tax Type

Capital Gains

Max ST Capital Gains Rate

39.60%

Max LT Capital Gains Rate

20.00%

Primary Advisor

Van Eck Associates Corp.

Distributor

Van Eck Securities Corp.

PPH provides exposure to the largest, US-listed multinational pharmaceutical giants in the world. The fund holds just 25 securities, including big weights in household names. Like the underlying pharmaceutical market, PPH is top heavy and has to reweight its big holdings to accommodate RIC diversification requirements, capping a single issuer to 20%. Still, it captures the space well, even after excluding Asia entirely. Overall, PPH is a great option for investors seeking exposure to big, multinational pharma companies. The index is reviewed on a semi-annual basis.